#MelanomaResearch
Happy to join the world of #academicmedicine #academicsurgery #surgicaloncology #cancerbiology #melanoma #melanomaresearch #immunooncology #tumorimmuneinteractions #cancerMD & all science topics. I'm a surgeon, translational researcher, mom, and cancer immunologist at MGH Surgery, Harvard Med
November 13, 2024 at 1:16 PM
A significant stride in cancer treatment! 🎉 Moderna & Merck's mRNA vaccine succeeded in late-stage melanoma trials, bringing exciting new hope for patients. #CancerVaccine #MelanomaResearch #MedicalBreakthrough
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
www.statnews.com
August 19, 2026 at 3:00 PM
Save the Date
Join us Thu 19 Nov (9am–5pm) at Sofitel Melbourne for the 2026 MASC Trials Scientific Meeting, a satellite meeting of the Australasian Melanoma Conference (19–21 Nov).
✅ Register now: www.melanoma2026.com/registration
#MASCTrials #MelanomaResearch #ClinicalTrials #SaveTheDate
April 9, 2026 at 1:41 AM
New @UCSDMedSchool.bsky.social research shows that a natural peptide can slow #melanoma growth, curb metastasis, and restore drug sensitivity in resistant tumors, taking a promising step toward safer and more effective #cancer therapies! #MelanomaResearch #CancerTherapy
Naturally Occurring Molecule May Help Outsmart Melanoma
Researchers from UC San Diego have uncovered a new possibility for treating melanoma, and it's something we have in our bodies already.
buff.ly
May 27, 2026 at 2:02 PM
Congratulations to Ludwig Cancer's Prof Colin Goding, who has been presented with the Lifetime Achievement Award from the Society for Melanoma Research🎉 Each year, the award is presented to someone who has made major contributions to #MelanomaResearch 🔬

Read more 👉 https://buff.ly/3EJuqDJ
February 18, 2025 at 1:51 PM
Excited to share this new paper from Dr Sam Kahler & team. 3D total body photography + AI identified cutaneous phenotypes linked to late-onset invasive melanoma risk, advancing personalised melanoma risk stratification.

🔗 academic.oup.com/bjd/advance-...

#MelanomaResearch #3DImaging #Dermatology
November 12, 2025 at 2:23 AM
So excited and proud to be a co-author on our new preprint: "Midkine inhibits dormancy of disseminated melanoma cells." Huge congrats to Carolina Rodriguez-Tirado & Maria Soledad Sosa for leading this fantastic work! 🎉 #MelanomaResearch #CancerDormancy #Midkine
June 18, 2025 at 6:36 AM
High-dimensional mapping reveals human CEACAM1's unique expression on immune cells, linking it to melanoma drug resistance. Understanding CEACAM1 may help tackle treatment challenges. #MelanomaResearch PMID:38956268, Commun Med (Lond) 2024 https://doi.org/10.1038/s43856-024-00525-8
February 4, 2025 at 12:10 PM
Dissecting melanoma? Check out which predictive models ace SLNB positivity risk, based on a meta-analysis of models up to 2024! #MelanomaResearch PMID:40072444, JAMA Dermatol 2025 https://doi.org/10.1001/jamadermatol.2025.0113 #Medsky #Pharmsky #RNA 🧪
https://doi.org/10.1001/jamadermatol.2025.0113
No description available
doi.org
March 21, 2025 at 4:10 AM
Some recent research from my lab in Hospital Albert Einstein - Center for Research in Immuno-oncology in Sao Paulo, Brazil. Insights to immune markers influencing melanoma patients' responses to neoadjuvant immunotherapy. #MelanomaResearch #Immunotherapy #MedicalResearch
www.cell.com/heliyon/full...
Immune mechanisms and predictive biomarkers related to neoadjuvant immunotherapy response in stage III melanoma
The treatment for stage III melanoma has advanced significantly, nevertheless, a substantial proportion of patients experience relapse. Neoadjuvant immune checkpoint blockade has emerged as a promisin...
www.cell.com
February 6, 2025 at 2:48 PM
Cancer treatments are not just about the drugs; timing matters too! Researchers struggle with conflicting data on the effectiveness of melanoma treatments. 🚧❌💉 #MelanomaResearch https://fefd.link/UmPnu
August 19, 2026 at 3:50 PM
Phase 3 results: combining the immune-modulatory cancer vaccine IO102-IO103 with pembrolizumab extended progression-free survival in untreated advanced melanoma; without significant added toxicity. #TCSC #Cancer #Oncology #MelanomaResearch
www.cancertherapyadvisor.com/news/immune-...
Immune-Modulatory Cancer Vaccine Extends PFS in Advanced Melanoma
Investigators analyzed the immune-modulatory cancer vaccine IO102-IO103 plus pembrolizumab for PFS in patients with untreated advanced melanoma.
www.cancertherapyadvisor.com
May 6, 2026 at 8:36 AM
New phase 3 data: adding the immune-modulatory vaccine IO102-IO103 to pembrolizumab appears to extend progression-free survival in treatment-naive advanced melanoma; without toxicity. Cancer vaccines are advancing fast. #TCSC #Oncology #MelanomaResearch

www.cancertherapyadvisor.com/news/immune-...
Immune-Modulatory Cancer Vaccine Extends PFS in Advanced Melanoma
Investigators analyzed the immune-modulatory cancer vaccine IO102-IO103 plus pembrolizumab for PFS in patients with untreated advanced melanoma.
www.cancertherapyadvisor.com
May 5, 2026 at 5:13 PM
Uveal melanoma may be rare, but innovation is accelerating. Targeted liver-directed therapies like HEPZATO are giving clinicians new options and patients new hope.

#CancerTreatment #MelanomaResearch #PrecisionMedicine #TCSC
March 8, 2026 at 7:16 AM
We are delighted to invite research proposals for patient and public benefit from clinicians/scientists and nurses/AHPs in the field of melanoma. Potential funding is up to £20,000.*

Learn more 👉 buff.ly/WGwRfmf

#melanoma #melanomaresearch
December 16, 2025 at 8:32 AM
Featured today by @MSKLibrary: pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy

#MelanomaResearch #pTERTMutation #Immunotherapy #CancerGenomics #OncologyStudies #StageIVMelanoma #SurvivalBiomarkers

dx.doi.org/10.1016/j.ej...
April 2, 2025 at 4:20 PM
🌍 USA:
mRNA technology is back, now fighting melanoma with a personalized cancer vaccine made just for you. This tailored approach marks a significant development in cancer treatment. #CancerVaccine #mRNA #MelanomaResearch
June 1, 2026 at 5:30 PM
Exploring medicinal mechanism of baicalin in tumor microenvironment of melanoma via bioinformatic and in vitro study.
Dang, Bingrong et al.
Paper
Details
#Baicalin #MelanomaResearch #TumorMicroenvironment
December 27, 2025 at 9:02 AM
Treatment Strategy Stops Malignant Melanoma in It Tracks
Melanoma's spread was halted in 80% of cases by shrinking tumors and priming patients' immune systems before surgery. www.thedoctorwillseeyounow.com/content/canc... @mdanderson.bsky.social #immunotherapy#melanomaresearch #melanoma #skincancer
A Promising New Treatment Strategy Stops Malignant Melanoma in It Tracks
Melanoma's spread was halted in 80% of cases over four years by shrinking tumors and priming patients' immune systems <i>before</i> surgery.
www.thedoctorwillseeyounow.com
July 16, 2025 at 2:04 PM
Thank you to our community of dermatologists for your dedication to early detection & innovative treatments. Together, we're working towards a future free from melanoma. #NationalDermatologistDay #MelanomaResearch
March 13, 2025 at 8:57 PM
In 2024, MRA made strides in research, awareness, and support for the melanoma community.

Thanks to you, we’ve advanced science, supported patients, and built connections. Let’s keep the momentum going in 2025 to drive progress and save lives!

#CureMelanoma #MelanomaResearch
January 2, 2025 at 7:32 PM